Vadadustat for the treatment of adults with symptomatic anaemia on dialysis for chronic kidney disease

NICE

23 January 2025 - NICE has published final evidence-based recommendations on the use of vadadustat (Vafseo) for the treatment of adults with symptomatic anaemia on dialysis for chronic kidney disease.

Vadadustat is recommended as an option for the treatment of adults with symptomatic anaemia due to chronic kidney disease on maintenance dialysis only if Medice provides it according to the commercial arrangement.

Read NICE technology appraisal guidance

Michael Wonder

Posted by:

Michael Wonder